Skip to main content
. Author manuscript; available in PMC: 2014 Sep 15.
Published in final edited form as: Cochrane Database Syst Rev. 2011 Oct 5;(10):CD003175. doi: 10.1002/14651858.CD003175.pub2

Figure 11.

Figure 11

Treatment hazard ratio from GOG 122 with 95% CI by prognostic group and end point. (A) Progression-free survival; (B) overall survival. AP, doxorubicin and cisplatin; WAI, whole-abdominal irradiation; HR, hazard ratio; Relative Hazard, treatment hazard ratio estimate; Var[In(HR)], variance of the log treatment hazard ratio estimate.